Timothy J. Eberlein

Timothy J. Eberlein's AcademicInfluence.com Rankings

Timothy J. Eberlein

Medical

#1850

World Rank

#2228

Historical Rank

Oncology

#99

World Rank

#103

Historical Rank

Surgery

#140

World Rank

#185

Historical Rank

medical Degrees

Timothy J. Eberlein

Philosophy

#5493

World Rank

#8310

Historical Rank

Logic

#2761

World Rank

#3796

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Timothy J. Eberlein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Timothy J. Eberlein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation (2012) (1636)
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1 (2002) (1523)
Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. (1995) (481)
The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy (1994) (465)
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis (2013) (437)
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer (2006) (414)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1 (2009) (369)
T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. (1994) (313)
Durable Complete Responses in Heavily Pretreated Patients with metastatic Melanoma Using T-Cell Transfer Immunotherapy (2012) (300)
Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology (2007) (275)
Prognostic Factors Predictive of Survival for Truncal and Retroperitoneal Soft‐Tissue Sarcoma (1995) (266)
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial. (2010) (262)
Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy (1996) (257)
Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011 (2009) (249)
Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. (1982) (233)
Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue Sarcoma (1994) (216)
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer (2017) (209)
Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. (1993) (207)
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer (2009) (191)
HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. (1994) (187)
Surgical Resection of the Primary Tumor is Associated with Increased Long-Term Survival in Patients with Stage IV Breast Cancer after Controlling for Site of Metastasis (2007) (185)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma (2012) (175)
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial (2008) (167)
T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. (1995) (156)
Expression and function of galectin‐3, a β‐galactoside‐binding protein in activated T lymphocytes (2001) (148)
Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer (2009) (144)
The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. (1991) (141)
Biopsy of occult breast lesions. Analysis of 1261 abnormalities. (1990) (132)
Depletion of CD4+CD25+ Regulatory T Cells Promotes a Tumor-Specific Immune Response in Pancreas Cancer–Bearing Mice (2006) (130)
Induction of Th17 Cells in the Tumor Microenvironment Improves Survival in a Murine Model of Pancreatic Cancer (2010) (126)
Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer. (1995) (125)
Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells (1984) (118)
Increased Prevalence of Regulatory T Cells (Treg) is Induced by Pancreas Adenocarcinoma (2006) (118)
Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study. (1995) (116)
Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells. (1988) (115)
Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand. (1999) (113)
Ensuring Equity, Diversity, and Inclusion in Academic Surgery: An American Surgical Association White Paper (2018) (111)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab (2012) (108)
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. (1996) (103)
Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. (2007) (100)
Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer (2009) (96)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status (2012) (95)
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial (2007) (94)
The HER2/neu‐derived peptide p654–662 is a tumor‐associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes (1997) (90)
Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations. (1984) (88)
Short-term Endpoints of Conventional Versus Laparoscopic-Assisted Surgery in Patients With Colorectal Cancer (MRC CLASICC Trial): Multicentre, Randomised Controlled TrialGuillou PJ, for the MRC CLASICC Trial Group (St James's Univ Hosp, Leeds, England; et al) Lancet 365:1718–1726, 2005§ (2006) (84)
Predictors of Primary Breast Abscesses and Recurrence (2009) (76)
Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer. (1994) (75)
Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction (2007) (71)
Circulating Mesothelin Protein and Cellular Antimesothelin Immunity in Patients with Pancreatic Cancer (2009) (71)
Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T‐cell activation (1999) (71)
Prospective evaluation of immediate reconstruction after mastectomy. (1993) (70)
HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. (1993) (70)
Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer. (2009) (69)
T-cell recognition of ovarian cancer. (1993) (69)
Interleukin‐2 Initiates Metabolic Responses Associated with Critical Illness in Humans (1988) (68)
Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex. (1990) (66)
Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma (2011) (65)
Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma (2009) (65)
Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. (2001) (65)
Thoracic Epidural Anesthesia Improves Outcome After Breast Surgery (1993) (65)
Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy (2008) (61)
Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. (1990) (60)
Long-term salvageability for patients with locally recurrent soft-tissue sarcomas. (1992) (59)
Mechanical bowel preparation for elective colorectal surgery: a multicentre randomised trial (2009) (59)
Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006 (2011) (58)
Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cells. (1989) (58)
Treatment and outcomes of patients with primary breast sarcoma. (2008) (57)
Margin Clearance and Outcome in Resected Pancreatic Cancer (2010) (56)
CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. (1993) (56)
Decision Aids and Breast Cancer: Do They Influence Choice for Surgery and Knowledge of Treatment Options? (2008) (54)
Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response (2011) (54)
Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. (2012) (54)
Impact of the COVID-19 Pandemic on Surgical Training and Learner Well-Being: Report of a Survey of General Surgery and Other Surgical Specialty Educators (2020) (54)
Metastatic disease to the breast: the Washington University experience (2007) (53)
Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN) (2001) (51)
Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients. (2008) (49)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer (2011) (48)
Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes. (1998) (46)
Surgical management of soft-tissue sarcoma. (1997) (46)
Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified? (2009) (45)
The impact of breast MRI on surgical decision‐making: Are patients at risk for mastectomy? (2009) (44)
Gastric Carcinoma Following Operation for Peptic Ulcer Disease (1978) (42)
Shared T cell epitopes in epithelial tumors. (1995) (42)
In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor. (1981) (41)
Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacy. (1994) (40)
How Many Sentinel Lymph Nodes Are Enough During Sentinel Lymph Node Dissection for Breast Cancer (2009) (39)
Immunomodulatory Effects of Interleukin‐12 on Human Tumor‐Infiltrating Lymphocytes (1993) (39)
A new regimen of interleukin 2 and lymphokine-activated killer cells. Efficacy without significant toxicity. (1988) (39)
Circumferential Margin Involvement is the Crucial Prognostic Factor after Multimodality Treatment in Patients with Locally Advanced Rectal Carcinoma (2009) (38)
Are We Overtreating Papillomas Diagnosed on Core Needle Biopsy? (2011) (38)
Solid-phase anti-CD3 antibody activation of murine tumor-infiltrating lymphocytes. (1990) (38)
Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma (2010) (38)
Trends in Morbidity and Mortality after Hepatic Resection for Hepatocellular Carcinoma: An Institute's Experience with 625 Patients (2008) (38)
TCR V beta 3+ and V beta 6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancers. (1994) (37)
Breast cancer in elderly women (≥80 years): variation in standard of care? (2011) (37)
Scientific Presentation Award. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction. (2007) (36)
Time to Disease Recurrence in Basal-Type Breast Cancers: Effects of Tumor Size and Lymph Node Status (2010) (35)
Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer. (1997) (34)
Local, Regional, and Systemic Recurrence Rates in Patients Undergoing Skin-Sparing Mastectomy Compared With Conventional Mastectomy (2012) (34)
Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma. (2001) (34)
Interleukin-2-induced lung injury is mediated by oxygen free radicals. (1991) (33)
Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70. (1994) (33)
Benign schwannoma of the esophagus presenting as a giant fibrovascular polyp. (1992) (33)
Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation (2012) (33)
Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer. (1982) (32)
A Tat Fusion Protein–Based Tumor Vaccine for Breast Cancer (2004) (32)
Thoracic epidural anesthesia improves outcome after breast surgery. (1993) (32)
An institutional strategy to increase minority recruitment to therapeutic trials (2013) (32)
Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound. (2016) (31)
Laparoscopic Surgery for Gastric Cancer: A Collective Review with Meta-Analysis of Randomized Trials (2011) (31)
Surgical Training and the Early Specialization Program: Analysis of a National Program. (2016) (30)
Major Hepatectomy for Hilar Cholangiocarcinoma Type 3 and 4: Prognostic Factors and Longterm Outcomes (2008) (30)
Mesorectal Grades Predict Recurrences After Curative Resection for Rectal Cancer (2008) (30)
T cell receptor Vβ2 and Vβ6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer (1993) (30)
A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer. (2013) (30)
Current management of carcinoma of the breast. (1994) (29)
Immunoregulatory effects of CD4+ T helper subsets in human melanoma. (1995) (29)
Efficacy of specimen radiography of clinically occult noncalcified breast lesions. (1988) (28)
Induction of Antigen-Specific CTL by Recombinant HIV Trans-Activating Fusion Protein-Pulsed Human Monocyte-Derived Dendritic Cells 1 (2003) (28)
Influence of Frozen-Section Analysis of Sentinel Lymph Node and Lumpectomy Margin Status on Reoperation Rates in Patients Undergoing Breast-Conservation Therapy (2009) (28)
Lymph Node Status and TS Gene Expression Are Prognostic Markers in Stage II/III Rectal Cancer After Neoadjuvant Fluorouracil-Based Chemoradiotherapy (2008) (28)
Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells (2005) (27)
Human dendritic cells induce tumor‐specific apoptosis by soluble factors (2002) (27)
Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer. (2013) (27)
Lymphedema Therapy Reduces the Volume of Edema and Pain in Patients with Breast Cancer (2008) (27)
The Rapid Induction by Interleukin‐2 of Pulmonary Microvascular Permeability (1989) (27)
Clinical Significance of miR-146a in Gastric Cancer Cases (2012) (26)
Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon Cancer (2011) (26)
Local secretion of IFN-gamma induces an antitumor response: comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells. (1999) (26)
The influence of angiogenesis inhibitor AGM‐1470 on immune system status and tumor growth in vitro (1993) (26)
Delivering High-Quality Cancer Care: The Critical Role of Quality Measurement. (2014) (26)
Activation of the Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Signaling Pathways Are Associated With Shortened Survival in Patients With Malignant Peritoneal Mesothelioma (2012) (26)
Modification of the HER2/NEU‐derived tumor antigen GP2 improves induction of GP2‐reactive cytotoxic T lymphocytes (2001) (25)
Role of thromboxane in interleukin 2-induced lung injury in sheep. (1989) (25)
Ibuprofen causes reduced toxic effects of interleukin 2 administration in patients with metastatic cancer. (1989) (24)
Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer. (1992) (24)
Postmastectomy Complications in Breast Reconstruction (1994) (23)
Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma (2009) (23)
Longterm Favorable Results of Limited Hepatic Resections for Patients with Hepatocellular Carcinoma: 20 Years of Experience (2008) (23)
MITI minimum information guidelines for highly multiplexed tissue images (2021) (22)
Mammaglobin-A is a tumor-associated antigen in human breast carcinoma. (2003) (22)
Accuracy of Endorectal Ultrasonography and Computed Tomography for Restaging Rectal Cancer after Preoperative Chemoradiation (2009) (22)
Micrometastatic Disease and Isolated Tumor Cells as a Predictor for Additional Breast Cancer Axillary Metastatic Burden (2010) (22)
Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence. (2008) (21)
Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma (2010) (20)
Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells. (1997) (20)
A Novel Automated Assay for the Rapid Identification of Metastatic Breast Carcinoma in Sentinel Lymph Nodes (2012) (20)
Results of radical radiotherapy for inflammatory breast cancer. (1991) (19)
Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor (1982) (19)
Key Tenets of Effective Surgery Leadership: Perspectives From the Society of Surgical Chairs Mentorship Sessions. (2016) (19)
Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study. (2013) (19)
Disease Recurrence in Sentinel Node-Positive Breast Cancer Patients Forgoing Axillary Lymph Node Dissection (2012) (19)
The American College of Surgeons Responds to COVID-19 (2020) (19)
Relationship Between Age and Axillary Lymph Node Involvement in Women With Breast Cancer (2010) (18)
Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancer. (1995) (18)
Height, weight, and risk of breast cancer relapse (1985) (18)
TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer (2012) (18)
Perpendicular Inked Versus Tangential Shaved Margins in Breast-Conserving Surgery: Does the Method Matter? (2008) (17)
Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma. (1982) (17)
A new paradigm in surgical training. (2014) (17)
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized Clinical Trial (2012) (17)
Cancer Therapy : Preclinical In fl ammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer : A Role for Targeting the CCL 2 / CCR 2 Axis (2013) (16)
Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients (2010) (16)
Classification of CD4+ T helper cell clones in human melanoma. (1994) (16)
Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies (2008) (16)
Soft-tissue sarcomas. (2000) (16)
Menstrual Cycle and Surgical Treatment of Breast Cancer: Findings From the NCCTG N9431 Study (2011) (16)
Biomarkers Predict Outcomes Following Cytoreductive Surgery for Hepatic Metastases from Functional Carcinoid Tumors (2008) (16)
Complete Cytoreduction Offers Longterm Survival in Patients with Peritoneal Carcinomatosis from Appendiceal Tumors of Unfavorable Histology (2010) (15)
Long-term Survival and Metastatic Pattern of Pancreatic and Periampullary Cancer After Adjuvant Chemoradiation or Observation: Long-term Results of EORTC Trial 40891 (2009) (15)
Management of Early Rectal T1 and T2 Cancers (2009) (15)
Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanoma. (1997) (15)
Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neu. (1999) (14)
Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy (2010) (14)
In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumour. (1995) (14)
Surgical Margins in Breast-Conservation Operations for Invasive Carcinoma: Does Neoadjuvant Chemotherapy Have an Impact? (2009) (13)
Consensus Statement on Mandatory Registration of Clinical Trials (2007) (13)
Abstract S6-05: A phase II trial of neoadjuvant palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with anastrozole for clinical stage 2 or 3 estrogen receptor positive HER2 negative (ER+HER2-) breast cancer (BC) (2016) (13)
Significance of Multifocality in Ductal Carcinoma In Situ: Outcomes of Women Treated With Breast-Conserving Therapy (2009) (13)
How Useful Are Clinical, Biochemical, and Cross-Sectional Imaging Features in Predicting Potentially Malignant or Malignant Cystic Lesions of the Pancreas? Results from a Single Institution Experience with 220 Surgically Treated Patients (2009) (13)
Breast-Conserving Surgery Using Projection and Reproduction Techniques of Surgical-Position Breast MRI in Patients with Ductal Carcinoma In Situ of the Breast (2009) (13)
Preoperative Biliary Drainage for Cancer of the Head of the Pancreas (2011) (12)
Racial Disparities in the Use of Radiotherapy After Breast-Conserving Surgery: A National Medicare Study (2011) (12)
Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection. (1995) (12)
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyCarey LA, Perou CM, Livasy CA, et al (Univ of North Carolina, Chapel Hill; Duke Univ, Durham, NC; Univ of British Columbia, Vancouver, Canada; et al) JAMA 295:2492–2502, 2006§ (2007) (12)
Colon and Rectal Cancer: Laparoscopic or Open? (2009) (12)
T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer. (1993) (11)
Tumor Biology and Tumor Markers (2012) (11)
The biological effects of immunosuppression on cellular immunotherapy. (1992) (11)
Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer (2012) (11)
Survival characteristics of metastatic renal cell carcinoma patients treated with lymphokine-activated killer cells plus interleukin-2. (1993) (10)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy (2011) (10)
Variations in Referral Patterns to High-Volume Centers for Pancreatic Cancer (2010) (10)
B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor. (2000) (10)
Simplified techniques for the isolation of alloreactive cell lines and clones with specific cytotoxic or proliferative activity. (1983) (10)
Consensus statement on mandatory registration of clinical trials (2007) (10)
DNA vaccination targeting mesothelin combined with anti-GITR antibody induces rejection of pancreatic adenocarcinoma (2006) (10)
Recurrence After Transanal Excision of T1 Rectal Cancer: Should We Be Concerned? (2006) (10)
Incidence and Patterns of Recurrence after Intersphincteric Resection for Very Low Rectal Adenocarcinoma (2009) (10)
Occult Tumor Burden Predicts Disease Recurrence in Lymph Node–Negative Colorectal Cancer (2012) (9)
Interim Analysis of a Prospective Multi-Institutional Study of Surgery Resident Experience with Flexibility in Surgical Training. (2018) (9)
Compromised margins following mastectomy for stage I-III invasive breast cancer. (2012) (9)
Survival After Adjuvant Oophorectomy and Tamoxifen in Operable Breast Cancer in Premenopausal Women (2009) (9)
Postoperative Morbidity with Diversion after Low Anterior Resection in the Era of Neoadjuvant Therapy: A Single Institution Experience (2010) (9)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality (2011) (8)
THE COMBINATION OF AXILLARY ULTRASOUND AND ULTRASOUND-GUIDED BIOPSY IS AN ACCURATE PREDICTOR OF AXILLARY STAGE IN CLINICALLY NODE-NEGATIVE BREAST CANCER PATIENTS (2014) (8)
Tumor Border Configuration Added to TNM Staging Better Stratifies Stage II Colorectal Cancer Patients Into Prognostic Subgroups (2010) (8)
Consensus Statement on the Adoption of the COPE Guidelines (2010) (8)
Biopsy of Occult Breast Lesions and Professional Liability-Reply (1990) (8)
Mechanisms of Radiocolloid Localization in Sentinel Node Biopsy (2000) (8)
Hepatic Arterial Infusion of Doxorubicin-Loaded Microsphere for Treatment of Hepatocellular Cancer: A Multi-Institutional Registry (2012) (8)
Is There a Role for Routine Use of MRI in Selection of Patients for Breast-Conserving Cancer Therapy? (2009) (8)
Experimental retained antrum. Diagnostic technics and histopathologic correlations. (1978) (7)
Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans (2005) (7)
Radical Antegrade Modular Pancreatosplenectomy Procedure for Adenocarcinoma of the Body and Tail of the Pancreas: Ability to Obtain Negative Tangential Margins (2008) (7)
The systemic complement activation caused by interleukin‐2/lymphokine‐activated killer‐cell therapy of cancer causes minimal systemic neutrophil activation (1991) (7)
Preoperative Chemotherapy: Where Do We Go from Here? (1993) (7)
Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy (2010) (7)
Vaccine therapy for cancer (1996) (7)
Characteristics and Treatment Modalities for African American Women Diagnosed With Stage III Breast Cancer (2010) (7)
Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitro (1996) (6)
Wound Management In Diabetic Foot Ulcer (DFU) - Incremental Cost-Analysis Of Treating Diabetic Neuropathic Foot Lesions With Adjunct Hemoglobin Contact Spray In Germany (2017) (6)
Prevention of hypocalcemia by administration of homologous plasma during experimental hemorrhagic pancreatitis in the pig. (1977) (6)
The role of interleukin-2 in cancer immunotherapy. (1991) (6)
Ductal Carcinoma In Situ Treated With Breast-Conserving Surgery and Accelerated Partial Breast Irradiation: Comparison of the MammoSite Registry Trial With Intergroup Study E5194 (2012) (6)
REGRESSION OF A DISSEMINATED SYNGENEIC SOLID TUMOR (2003) (6)
Secondary cytokine production by lymphoid cells used in cellular immunotherapy. (1992) (6)
Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer (2015) (6)
T Cells Mediate Treatment of Six-Day-Old Cytokine-Gene-Transfected Mouse Mammary Tumor (1999) (6)
Association of Age and Survival in Patients With Gastroesophageal Cancer Undergoing Surgery With or Without Preoperative Therapy (2010) (5)
Clinical and Economic Comparison of Laparoscopic to Open Liver Resections Using a 2-to-1 Matched Pair Analysis: An Institutional Experience (2012) (5)
Breast reconstruction (1994) (5)
Augmentation of tumor-infiltrating lymphocyte cytotoxicity following activation with anti-CD3 antibodies (1988) (5)
Treatment of Established Tumor Is Associated with ICAM-1 Upregulation and Reversed by CD8 Depletion in a Tumor Necrosis Factor-Alpha Gene Transfected Mouse Mammary Tumor (1999) (5)
Expert Panel Offers Advice to Improve Screening Rates for Colorectal Cancer (2011) (4)
Radiation Therapy for Ductal Carcinoma In Situ: A Decision Analysis (2012) (4)
Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumors (1995) (4)
Patterns of Treatment for Early Stage Breast Cancers at the M. D. Anderson Cancer Center From 1997 to 2004 (2010) (4)
Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study (2010) (4)
Assessing the State of Surgical Oncology: The Future Is Now (2006) (4)
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal CancerPagès F, Berger A, Camus M, et al (Univ Paris 6; Georges Pompidou European Hosp, Paris; Graz Univ of Technology, Austria) N Engl J Med 353:2654–2666, 2005§ (2007) (4)
Surgical Management of Advanced Gastrointestinal Stromal Tumors After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors (2008) (4)
A Randomized Trial of Ex vivo CD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: Tumor-Specific Immune Responses Are Associated with Improved Survival (2012) (4)
Prognosis of patients with advanced melanoma. (1995) (4)
Sentinel Node Biopsy Alone for Node-Positive Breast Cancer: 12-Year Experience at a Single Institution (2012) (3)
A Combination of Serum Markers for the Early Detection of Colorectal Cancer (2012) (3)
Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group (2011) (3)
Bladder and Sexual Function Following Resection for Rectal Cancer in a Randomized Clinical Trial of Laparoscopic versus Open TechniqueJayne DG, Brown JM, Thorpe H, et al (Univ of Leeds, England) Br J Surg 92:1124–1132, 2005§ (2006) (3)
Approaches to immunotherapy of cancer: characterization of lymphokines as second signals for cytotoxic T-cell generation. (1991) (3)
Gene Signature Is Associated with Early Stage Rectal Cancer Recurrence (2011) (3)
Accuracy of Surgical Diagnosis in Detecting Early Gastric Cancer and Lymph Node Metastasis and Its Role in Determining Limited Surgery (2010) (3)
Percutaneous Transesophageal Gastrostomy Tube for Decompression of Malignant Obstruction: Report of the First Case and Our Series in the US (2007) (3)
A tat fusion protein-based tumor vaccine for breast cancer (2006) (2)
GATA-3 Expression as a Predictor of Hormone Response in Breast CancerParikh P, Palazzo JP, Rose LJ, et al (Thomas Jefferson Univ, Philadelphia) J Am Coll Surg 200:705–710, 2005§ (2006) (2)
Does Failure to Visualize a Sentinel Node on Preoperative Lymphoscintigraphy Predict a Greater Likelihood of Axillary Lymph Node Positivity (2008) (2)
Dextrocholedocholithiasis: calculous obstruction complicating double ductus choledochus in an adult. (1993) (2)
Depletion of regulatory T cells promotes a tumor-specific immune response (2004) (2)
A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach (2008) (2)
Effect of High Perioperative Oxygen Fraction on Surgical Site Infection and Pulmonary Complications After Abdominal Surgery: The PROXI Randomized Clinical Trial (2010) (2)
Risk Factors for Anastomotic Leakage after Surgery for Colorectal Cancer: Results of Prospective Surveillance (2007) (2)
Mentorship program designed to advance women in academic surgery 6 (2009) (2)
A randomized multicenter trial to compare long term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers (2009) (2)
Risk Factors of Pancreatic Fistula and Delayed Gastric Emptying after Pancreaticoduodenectomy with Pancreaticogastrostomy (2008) (2)
Shaping a modern academic department of surgery: honoring the past; focusing on the future. (2012) (2)
Postmastectomy Radiation Improves Local-Regional Control and Survival for Selected Patients With Locally Advanced Breast Cancer Treated With Neoadjuvant Chemotherapy and MastectomyHuang EH, Tucker SL, Strom EA, et al (Univ of Texas, Houston) J Clin Oncol 22:4639–4647, 2004§ (2006) (2)
Long-Term Outcomes After Hepatic Resection for Colorectal Metastases in Young Patients (2011) (2)
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer (2007) (2)
T-cell subpopulations mediating rejection of solid syngeneic tumors after systemic adoptive immunotherapy. Abstr. (1983) (2)
Accuracy of Intraoperative Frozen-Section Analysis of Breast Cancer Lumpectomy-Bed MarginsCendán JC, Coco D, Copeland EM III (Univ of Florida, Gainesville) J Am Coll Surg 201:194–198, 2005§ (2006) (2)
Atlas of Surgical Oncology (1993) (2)
Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes. (2002) (2)
Impact of surgeon volume and specialization on short-term outcomes in colorectal cancer surgery (2008) (1)
Induction of CD4+25+FoxP3+ Regulatory T cells from naïve CD4+25-FoxP3- T cells in vivo by pancreas adenocarcinoma (2006) (1)
Intraoperative Evaluation of Breast Tumor Margins with Optical Coherence Tomography (2010) (1)
Effect of Neoadjuvant Therapy on Local Recurrence after Resection of Pancreatic Adenocarcinoma (2009) (1)
"The little red book"--sayings of chairman Brennan. (2007) (1)
Adjuvant Chemotherapy Improves Survival after Resection of Hepatic Colorectal Metastases: Analysis of Data from Two Continents (2008) (1)
Resection of Hepatocellular Carcinoma in Noncirrhotic Liver: Analysis of Risk Factors for SurvivalDupont-Bierre E, Compagnon P, Raoul J-L, et al (Centre Hospitalo-Universitaire Pontchaillou, Rennes, France; Centre Régional de Lutte Centre le Cancer, Rennes, France) J Am Coll Surg 201:663–670, 2005§ (2007) (1)
Noncardia Gastric Adenocarcinoma Remains an Important and Deadly Cancer in the United States: Secular Trends in Incidence and Survival (2008) (1)
Interleukin-2 leads to lung lymphosequestration, thromboxane generation, and rapid increase in permeability (1987) (1)
Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspirationMishra G, Zhao Y, Sweeney J, et al (Wake Forest Univ, Winston-Salem, NC; Univ of Missouri-Columbia) Gastrointest Endosc 63:648–654, 2006§ (2007) (1)
Surgeon Training, Protocol Compliance, and Technical Outcomes From Breast Cancer Sentinel Lymph Node Randomized Trial (2010) (1)
20-year experience with the treatment of gastric cancer since adopting a radical systemic lymph node dissection. (1996) (1)
Multicentre validation study of sentinel node biopsy for staging in breast cancerBergkvist L, for the Swedish Breast Cancer Group and the Swedish Society of Breast Surgeons (Uppsala Univ, Västerås, Sweden; Karolinska Univ, Stockholm; et al) Br J Surg 92:1221–1224, 2005§ (2007) (1)
Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation (2012) (1)
Small (<2.0-cm) Breast Cancers: Mammographic and US Findings at US-Guided Cryoablation—Initial ExperienceRoubidoux MA, Sabel MS, Bailey JE, et al (Univ of Michigan Comprehensive Cancer Ctr, Ann Arbor) Radiology 233:857–867, 2004§ (2006) (1)
A Multicenter Analysis of Distal Pancreatectomy for Adenocarcinoma: Is Laparoscopic Resection Appropriate? (2011) (1)
Clinical trials methods: a course for surgeons. (1999) (1)
With long-term lymphoid cell lines expanded in t cell growth factor. (1982) (1)
Presidential Forum Discussion: Development of Surgical Scientists. (2015) (1)
EUS-guided FNA of Pancreatic Metastases: A Multicenter ExperienceDeWitt J, Jowell P, LeBlanc J, et al (Indianapolis; Durham, NC; Mineola, NY) Gastrointest Endosc 61:689–696, 2005§ (2006) (1)
Relationship Between Hospital Volume, System Clinical Resources, and Mortality in Pancreatic Resection (2010) (1)
Fecal DNA Versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk PopulationImperiale TF, for the Colorectal Cancer Study Group (Indiana Univ, Indianapolis; et al) N Engl J Med 351:2704–2714, 2004§ (2006) (1)
Abstract OT3-5-01: A prospective, randomized trial of sentinel lymph node biopsy versus no additional staging in patients with T1-T2 invasive breast cancer and negative axillary ultrasound (2015) (1)
T Cells against Tumors (2002) (1)
Gifts and Grants (1981) (1)
Letter to the editor [4] (1993) (0)
A Double-blind Randomized Controlled Trial of Toremifen Therapy for Mastalgia (2007) (0)
JACS continues to gain recognition as an influential surgical journal: an interview with Timothy J. Eberlein, MD, FACS. Interview by Diane S. Schneidman. (2009) (0)
Ductal Carcinoma In Situ Treated With Breast-Conserving Surgery and Radiotherapy: A Comparison With ECOG Study 5194 (2012) (0)
Consensus statement on mandatory registration of clinical trials. (2007) (0)
Advances in Brief HER 2 / neu-derived Peptides Are Shared Antigens among Human Non-Small Cell Lung Cancer and Ovarian Cancer ' (2006) (0)
Attaining Negative Margins in Breast-Conservation Operations: Is There a Consensus among Breast Surgeons? (2010) (0)
The Spontaneous CD8+ T-Cell Response to HLA-A2–Restricted NY-ESO-1b Peptide in Hepatocellular Carcinoma PatientsShang X-Y, Chen H-S, Zhang H-G, et al (Peking Univ Health Science Ctr, Beijing, People's Republic of China; Guangxi Guilin Med College, People's Republic of China; Memorial Sloan-Kettering (2006) (0)
Breast-Conserving Surgery in Older Patients with Invasive Breast Cancer: Current Patterns of Treatment Across the United States (2010) (0)
An institutional strategy to increase minority recruitment to therapeutic trials (2010) (0)
Distribution of CD4(+)CD25high Regulatory T-Cells in Tumor-draining Lymph Nodes in Patients With Gastric CancerKawaida H, Kono K, Takahashi A, et al (Univ of Yamanashi, Japan) J Surg Res 124:151–157, 2005§ (2006) (0)
Selecting patients with young-onset colorectal cancer for mismatch repair gene analysis (2009) (0)
Large-Scale Investigation into Dumping Syndrome after Gastrectomy for Gastric Cancer (2011) (0)
Survival and Recurrence Rates after Resection for Hepatocellular Carcinoma in Noncirrhotic Livers (2008) (0)
PRODUCTION BY HUMAN OVARIAN, BREAST, AND PANCREATIC CANCER CELLS OF A HIGH MOLECULAR WEIGHT FACTOR SUPPRESSING ACTIVATION OF NAIVE IMMUNE CELLS (1997) (0)
Lysis of syngeneic murine lymphoma by lymphocytes sensitized and expanded in lectin-free t-cell growth factor (lf-tcgf). Abstr. (1981) (0)
Role of Imaging in the Preoperative Staging of Small Bowel Neuroendocrine Tumors (2011) (0)
Effect of Steatohepatitis Associated With Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal MetastasesFernandez FG, Ritter J, Goodwin JW, et al (Washington Univ School of Medicine, St Louis; St John's Clinic, Springfield, Mo) J Am Coll Surg 200:845–853, 2005§ (2006) (0)
Natural History of Patients with Subcentimeter Pulmonary Nodules Undergoing Hepatic Resection for Metastatic Colorectal Cancer (2010) (0)
Compromised Margins Following Mastectomy for Stage I-III Breast Cancer (2012) (0)
Abstract P5-14-07: Noninfectious Wound Complications after Mastectomy with and without Immediate Breast Reconstruction (2010) (0)
Clinical Significance of Frozen Section Analysis During Resection of Intraductal Papillary Mucinous Neoplasm: Should a Positive Pancreatic Margin for Adenoma or Borderline Lesion Be Resected Additionally? (2010) (0)
Swiss Society of Surgery (2004) (0)
Gene Expression Profiling of Nonneoplastic Mucosa May Predict Clinical Outcome of Colon Cancer Patients (2007) (0)
Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery (2010) (0)
Novel Pancreaticojejunostomy with a Low Rate of Anastomotic Failure-Related Complications (2010) (0)
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival In Colorectal Cancer: A Systematic Review and Meta-Analysis (2012) (0)
a Murine Model of Pancreatic Cancer inRegulatory T Cells Inhibits Tumor Growth Disruption of CCR 5-Dependent Homing of (2009) (0)
39 – Active Immunotherapy for Cancer (2001) (0)
Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis (2012) (0)
Quality of Life and Symptom Control after Stent Placement or Surgical Palliation of Malignant Colorectal Obstruction (2010) (0)
Book ReviewAdoptive Cellular Immunotherapy of Cancer (1990) (0)
Chapter 28 - Tumor Biology and Tumor Markers (2004) (0)
Decision Involvement and Receipt of Mastectomy Among Racially and Ethnically Diverse Breast Cancer Patients (2010) (0)
Breast Cancer Local Recurrence after Mastectomy and TRAM Flap Reconstruction: Incidence and Treatment OptionsHoward MA, Polo K, Pusic AL, et al (Mem Sloan-Kettering Cancer Ctr, New York) Plast Reconstr Surg 117:1381–1386, 2006§ (2007) (0)
Introduction of Dr. S. Eva Singletary (2005) (0)
Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer (2012) (0)
50-Year Appraisal of Gastrinoma: Recommendations for Staging and TreatmentEllison EC, Sparks J, Verducci JS, et al (Ohio State Univ, Columbus) J Am Coll Surg 202:897–905, 2006§ (2007) (0)
Dendritic Cells Protein-Pulsed Human Monocyte-Derived-Activating Fusion Trans Recombinant HIV Induction of Antigen-Specific CTL by (2003) (0)
B7.1 PROVIDES A STRONG COSTIMULATORY SIGNAL FOR AUTOLOGOUS T-CELLS IN RECOGNIZING HUMAN OVARIAN CANCER CELLS (1997) (0)
An Aggressive Surgical Approach Leads to Improved Survival in Patients With Gallbladder Cancer: A 12-Year Study at a North American Center (2006) (0)
Number of Lymph Node Metastases Is Better Predictor of Prognosis Than Level of Lymph Node Metastasis in Patients with Node-Positive Colon CancerSuzuki O, Sekishita Y, Shiono T, et al (Hokkaido Univ, Japan) J Am Coll Surg 202:732–736, 2006§ (2007) (0)
Lymphocytes Factor ) Producing Donor Tumor-Infiltrating Granulocyte / Macrophage Colony-Stimulating and γ Response Triggered by Cytokine ( IFN-Dependent on Induction of a Host Immune Successful Adoptive Cellular Immunotherapy (1997) (0)
Combined Blunt-Clamp Dissection and LigaSure Ligation for Hepatic Parenchyma Dissection: Postcoagulation Technique (2010) (0)
Consensus statement on the adoption of the COPE guidelines (2010) (0)
Axillary Recurrence Rate in Breast Cancer Patients With Negative Sentinel Lymph Node (SLN) or SLN Micrometastases: Prospective Analysis of 150 Patients After SLN Biopsy (2006) (0)
Initiation of a Critical Pathway for Pancreaticoduodenectomy at an Academic Institution—the First Step in Multidisciplinary Team Building (2008) (0)
Late results of skin-sparing mastectomy followed by immediate breast reconstruction (2009) (0)
Relationship Between Number of Breast Cancer Operations Performed and 5-Year Survival After Treatment for Early-Stage Breast Cancer (2008) (0)
Immediate Radical Resection After Local Excision of Rectal Cancer: An Oncologic Compromise?Hahnloser D, Wolff BG, Larson DW, et al (Mayo Clinic, Rochester, Minn) Dis Colon Rectum 48:429–437, 2005§ (2006) (0)
Effect of Occult Metastases on Survival in Node-Negative Breast Cancer (2012) (0)
Breast Adenocarcinoma Microenvironment of Patients with Pancreas in Peripheral Blood and Tumor Prevalence of Regulatory T Cells Is Increased (2002) (0)
Effect of neoadjuvant chemotherapy on bone marrow micrometastases in women with locally advanced breast cance. (2004) (0)
LYLE A. FRENCH, MD, PHD: 1915???2004 (2006) (0)
Utility of the GeneSearch Breast Lymph Node Assay for the Rapid Evaluation of Sentinel Lymph Nodes in Breast Cancer (2011) (0)
Addressing the Surgical Workplace: An Opportunity to Create a Culture of Belonging. (2022) (0)
Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer (2012) (0)
Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis (2012) (0)
Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma (2012) (0)
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial (2012) (0)
Book ReviewSurgical Care of the Elderly (1989) (0)
Comparison of Long-term Functional Results of Colonic J-Pouch and Straight Anastomosis After Low Anterior Resection for Rectal Cancer: A Five-Year Follow-up (2006) (0)
Autologous Breast Reconstruction: The Vanderbilt Experience (1998 to 2005) of Independent Predictors of Displeasing Outcomes (2009) (0)
Large Hepatocellular Carcinoma: Time to Stop Preoperative Biopsy (2008) (0)
Factors Associated with Early Recurrence after Resection for Hepatocellular Carcinoma and Outcomes (2007) (0)
RESISTANCE TO FAS-MEDIATED APOPTOSIS IN PANCREATIC CANCER CELLS (1997) (0)
[Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?"]. (1997) (0)
Phase I clinical trial of infusion into cancer patients of autologous lymphocytes activated in vitro with lectins (1982) (0)
Current Issues in Surgical Oncology Training (2002) (0)
Book Review The Ageing Surgical Patient: Anaesthetic, Operative and Medical Management Edited by D.L. Crosby, G.A.D. Rees, and D.G. Seymour. 457 pp., illustrated. New York, John Wiley, 1992. $149.95. 0-471-92847-X (1993) (0)
Predictors of Recurrence in Patients With T2 and Early T3, N0 Adenocarcinoma of the Rectum Treated by Surgery AloneNissan A, Stojadinovic A, Shia J, et al (Mem Sloan-Kettering Cancer Ctr) J Clin Oncol 24:4078–4084, 2006§ (2007) (0)
Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer (2010) (0)
Transanal Excision vs. Major Surgery for T1 Rectal CancerEndreseth BH, for The Norwegian Rectal Cancer Group (Univ of Trondheim, Norway; The Cancer Registry of Norway, Oslo; Levanger Hosp, Norway) Dis Colon Rectum 48:1380–1388, 2005§ (2007) (0)
Safety of Immediate Transverse Rectus Abdominis Myocutaneous Breast Reconstruction for Patients With Locally Advanced DiseaseFoster RD, Hansen SL, Esserman LJ, et al (Univ of California, San Francisco) Arch Surg 140:196–200, 2005§ (2006) (0)
The 55th volume of the Surgical Forum is dedicated to Murray F Brennan, MD, FACS (2004) (0)
Online Manuscript Submission (2004) (0)
Functional results of intersphincteric resection for low rectal cancer (2009) (0)
[Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes]. (1998) (0)
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?Mawdsley S, Glynne-Jones R, Grainger J, et al (Mount Vernon Cancer Centre, Middlesex, England; Barnet Gen Hosp, England; Watford Gen H (2007) (0)
Autologous Melanoma Vaccine Induces Antitumor and Self-Reactive Immune Responses That Affect Patient Survival and Depend on MHC Class II Expression on Vaccine Cells (2010) (0)
Preoperative Chemoradiotherapy and Total Mesorectal Excision Surgery for Locally Advanced Rectal Cancer: Correlation With Rectal Cancer Regression GradeWheeler JMD, Dodds E, Warren BF, et al (John Radcliffe Hosp, Oxford, England) Dis Colon Rectum 47:2025–2031, 2004§ (2006) (0)

This paper list is powered by the following services:

Timothy J. Eberlein's Academic­Influence.com Rankings

Why Is Timothy J. Eberlein Influential?

Timothy J. Eberlein's Published Works

Published Works

Timothy J. Eberlein's AcademicInfluence.com Rankings